However, insights into the structural positioning of detrimental mutants and their effects on Gi protein interactions offer opportunities for the development of targeted drugs, precision medicine strategies, and novel approaches to neurological disorders and cancer therapeutics. The gene discussed is GNAI1; the disease is nervous system disorder.